Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DM0VEBI)

Drug Name
6,6-fused nitrogenous heterocyclic compound 1 Drug Info
Synonyms PMID25656651-Compound-32a
Cross-matching ID
PubChem CID
68095484
TTD Drug ID
DM0VEBI

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Tyrosine-protein kinase ABL1 (ABL) TT3PJMV ABL1_HUMAN Inhibitor [1]

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Tyrosine-protein kinase ABL1 (ABL) DTT ABL1 6.28E-04 0.33 2.07
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412.